Sat. Jan 16th, 2021
AstraZeneca COVID-19 shot candidate shows promise in mid-stage trials - CGTN
(Photo Courtesy: http://www.cgtn.com)

United Kingdom-based drug firm AstraZeneca is ready to offer its vaccine for the coronavirus disease 2019 (Covid-19) it developed with Oxford University at $2.50 per dose, or almost a tenth of the cost of those offered by other drug firms.

AstraZenec said earlier it was ready to offer its Covid-19 vaccine under a “no-profit” pledge as its contribution to solve the worldwide health crisis.

“We need to be able to make a lot of vaccine for the world quickly, and it’s best if we can do it with different technologies so that if one technology runs into a roadblock, then we’ve got alternatives, we’ve got diversity,″ professor Sarah Gilbert, a leader of the Oxford team.The Oxford-AstraZeneca vaccine was 90-percent effective in preventing Covid-19 in one of the dosing regimens tested; it was less effective in another. Earlier this month, rival drugmakers Pfizer and Moderna reported preliminary results from late-stage trials showing their vaccines were almost 95-percent effective. SOVEREIGNPH

Leave a Reply